Samit R. Joshi

1.9k total citations
30 papers, 1.1k citations indexed

About

Samit R. Joshi is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Samit R. Joshi has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 17 papers in Virology and 8 papers in Emergency Medicine. Recurrent topics in Samit R. Joshi's work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (12 papers). Samit R. Joshi is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (12 papers). Samit R. Joshi collaborates with scholars based in United States, United Kingdom and Peru. Samit R. Joshi's co-authors include Albert C. Shaw, Alexander Panda, Hannah Greenwood, Janet M. Lord, Heather Allore, Feng Qian, Ruth R. Montgomery, Max Lataillade, George J. Hanna and David Stock and has published in prestigious journals such as Bioinformatics, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Samit R. Joshi

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samit R. Joshi United States 15 393 369 258 256 206 30 1.1k
W. L. William Chang United States 19 167 0.4× 575 1.6× 108 0.4× 646 2.5× 182 0.9× 30 1.3k
Simone Gonçalves Fonseca Brazil 24 349 0.9× 784 2.1× 380 1.5× 655 2.6× 366 1.8× 53 2.0k
Donato Torre Italy 17 262 0.7× 206 0.6× 188 0.7× 270 1.1× 123 0.6× 44 886
Jiming Yin China 17 381 1.0× 176 0.5× 136 0.5× 313 1.2× 244 1.2× 42 1.2k
Helena Ong United States 19 170 0.4× 489 1.3× 212 0.8× 328 1.3× 378 1.8× 25 1.3k
Javeed A. Shah United States 18 530 1.3× 391 1.1× 42 0.2× 383 1.5× 299 1.5× 40 1.5k
Cartesio D’Agostini Italy 17 178 0.5× 238 0.6× 66 0.3× 201 0.8× 187 0.9× 43 826
Angela Corpolongo Italy 17 546 1.4× 85 0.2× 578 2.2× 251 1.0× 80 0.4× 56 1.1k
Zhao Jia China 13 212 0.5× 431 1.2× 319 1.2× 129 0.5× 184 0.9× 37 883
Stéphanie Rose France 24 602 1.5× 788 2.1× 132 0.5× 412 1.6× 439 2.1× 45 1.6k

Countries citing papers authored by Samit R. Joshi

Since Specialization
Citations

This map shows the geographic impact of Samit R. Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samit R. Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samit R. Joshi more than expected).

Fields of papers citing papers by Samit R. Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samit R. Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samit R. Joshi. The network helps show where Samit R. Joshi may publish in the future.

Co-authorship network of co-authors of Samit R. Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Samit R. Joshi. A scholar is included among the top collaborators of Samit R. Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samit R. Joshi. Samit R. Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peese, Kevin M., Samit R. Joshi, Mark Krystal, et al.. (2024). Exploring HIV-1 Maturation: A New Frontier in Antiviral Development. Viruses. 16(9). 1423–1423. 5 indexed citations
3.
Zhang, Ying, et al.. (2023). Open‐label, drug–drug interaction study between the HIV‐1 maturation inhibitor GSK3640254 and a metabolic probe cocktail in healthy participants. British Journal of Clinical Pharmacology. 89(7). 2236–2245. 1 indexed citations
4.
Spinner, Christoph D., Franco Felizarta, Giuliano Rizzardini, et al.. (2022). Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. Clinical Infectious Diseases. 75(5). 786–794. 15 indexed citations
5.
Johnson, Mark, et al.. (2022). Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants. Clinical Pharmacology in Drug Development. 11(5). 632–639. 3 indexed citations
6.
Dumitrescu, Teodora Pene, Samit R. Joshi, Mark Johnson, et al.. (2021). A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants. Antimicrobial Agents and Chemotherapy. 65(6). 12 indexed citations
7.
Joshi, Samit R., Disala Fernando, Thomas Greene, et al.. (2020). Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor. Pharmacology Research & Perspectives. 8(6). e00671–e00671. 22 indexed citations
8.
Zhang, Sharon, Neelanjana Ray, Brett R. Beno, et al.. (2019). Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study. PLoS ONE. 14(10). e0224076–e0224076. 14 indexed citations
9.
10.
Lalezari, Jacob, Gulam Latiff, Cynthia Brinson, et al.. (2015). Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial. The Lancet HIV. 2(10). e427–e437. 50 indexed citations
11.
Thakar, Juilee, Subhasis Mohanty, A. Phillip West, et al.. (2015). Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination. Aging. 7(1). 38–52. 53 indexed citations
12.
Gupta, Samir K., Grace A. McComsey, Juan Echevarría, et al.. (2015). Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial. The Lancet HIV. 3(1). e13–e22. 9 indexed citations
13.
Lalezari, Jacob, Gulam Latiff, Cynthia Brinson, et al.. (2014). Safety profile of HIV‐1 attachment inhibitor prodrug BMS‐663068 in antiretroviral‐experienced subjects: week 24 analysis. Journal of the International AIDS Society. 17(4S3). 19530–19530. 4 indexed citations
14.
Brinson, Cynthia, Jacob Lalezari, Gulam Latiff, et al.. (2014). 540HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis. Open Forum Infectious Diseases. 1(suppl_1). S22–S23. 1 indexed citations
15.
Mohanty, Subhasis, Samit R. Joshi, Ikuyo Ueda, et al.. (2014). Prolonged Proinflammatory Cytokine Production in Monocytes Modulated by Interleukin 10 After Influenza Vaccination in Older Adults. The Journal of Infectious Diseases. 211(7). 1174–1184. 50 indexed citations
16.
Lalezari, Jacob, Gulam Latiff, Cynthia Brinson, et al.. (2014). 1574Safety Profile of HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Analysis. Open Forum Infectious Diseases. 1(suppl_1). S419–S419.
17.
Shaw, Albert C., Alexander Panda, Samit R. Joshi, et al.. (2010). Dysregulation of human Toll-like receptor function in aging. Ageing Research Reviews. 10(3). 346–353. 153 indexed citations
18.
Shaw, Albert C., Samit R. Joshi, Hannah Greenwood, Alexander Panda, & Janet M. Lord. (2010). Aging of the innate immune system. Current Opinion in Immunology. 22(4). 507–513. 466 indexed citations
19.
Wormser, Gary P., et al.. (2010). Emergence of Resistance to Azithromycin‐Atovaquone in Immunocompromised Patients withBabesia microtiInfection. Clinical Infectious Diseases. 50(3). 381–386. 92 indexed citations
20.
Joshi, Samit R., Albert C. Shaw, & Vincent Quagliarello. (2009). Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine.. PubMed. 82(4). 143–51. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. L. William Chang Breakdown of academic impact, for papers by Simone Gonçalves Fonseca Breakdown of academic impact, for papers by Donato Torre Breakdown of academic impact, for papers by Jiming Yin Breakdown of academic impact, for papers by Helena Ong Breakdown of academic impact, for papers by Javeed A. Shah Breakdown of academic impact, for papers by Cartesio D’Agostini Breakdown of academic impact, for papers by Angela Corpolongo Breakdown of academic impact, for papers by Zhao Jia Breakdown of academic impact, for papers by Stéphanie Rose
Rankless by CCL
2026